|
[1]YANG JD,HAINAUT P,GORES GJ,et al.A global view of hepatocellular carcinoma:Trends,risk,prevention and management[J].Nat Rev Gastroenterol Hepatol,2019,16(10):589-604．
|
|
[2]HEIMBACH JK,KULIK LM,FINN RS,et al.AASLD guidelines for the treatment of hepatocellular carcinoma[J].Hepatology,2018,67(1):358-380．
|
|
[3]OMATA M,CHENG AL,KOKUDO N,et al.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma:A2017 update[J].Hepatol Int,2017,11(4):317-370．
|
|
[4]DEWDNEY B,HEBBARD L.A novel role for polymeric immunoglobulin receptor in tumour development:Beyond mucosal immunity and into hepatic cancer cell transformation[J].Hepatobiliary Surg Nutr,2018,7(1):52-55．
|
|
[5]NIMMERJAHN F,RAVETCH JV.Fc-receptors as regulators of immunity[J].Adv Immunol,2007,96:179-204．
|
|
[6]ANDREU P,JOHANSSON M,AFFARA NI,et al.FcRgamma activation regulates inflammation-associated squamous carcinogenesis[J].Cancer Cell,2010,17(2):121-134．
|
|
[7]KAETZEL CS.The polymeric immunoglobulin receptor:Bridging innate and adaptive immune responses at mucosal surfaces[J].Immunol Rev,2005,206:83-99．
|
|
[8]TURULA H,WOBUS CE.The role of the polymeric immunoglobulin receptor and secretory immunoglobulins during mucosal infection and immunity[J].Viruses,2018,10(5):237．
|
|
[9]AI J,TANG Q,WU Y,et al.The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma[J].J Natl Cancer Inst,2011,103(22):1696-1712．
|
|
[10]YUE X,AI J,XU Y,et al.Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma[J].Hepatology,2017,65(6):1948-1962．
|
|
[11]TANG QJ,QI X,GENG MY.Important role of polymeric immunoglobulin receptor in mucosal immunity[J].Chin J Biochem Mol Biol,2007,23(9):724-729.(in Chinese)唐庆娟，戚欣，耿美玉．多聚免疫球蛋白受体(p IgR)在粘膜免疫中的重要功能[J]．中国生物化学与分子生物学报，2007,23(9):724-729．
|
|
[12]WEI HC.The bioinformatic research of PIGR and MYB gene family[D].Jinan:Shandong Normal University,2012.(in Chinese)魏海超．PIGR与MYB基因家族的生物信息学研究[D]．济南:山东师范大学，2012．
|
|
[13]ASANO M,KOMIYAMA K.Polymeric immunoglobulin receptor[J].J Oral Sci,2011,53(2):147-156．
|
|
[14]BERNTSSON J,LUNDGREN S,NODIN B,et al.Expression and prognostic significance of the polymeric immunoglobulin receptor in epithelial ovarian cancer[J].J Ovarian Res,2014,7:26．
|
|
[15]LIU F,YE P,BI T,et al.Colorectal polymeric immunoglobulin receptor expression is correlated with hepatic metastasis and poor prognosis in colon carcinoma patients with hepatic metastasis[J].Hepatogastroenterology,2014,61(131):652-659．
|
|
[16]KE QG,JIANG DQ,HUANG JC,et al.Clinical significance of polymeric immunoglobulin receptor in judging the recurrence and metastasis of liver cancer[J].Contemp Med,2014,20(11):92-93.(in Chinese)柯群刚，姜德清，黄继超，等．多聚免疫球蛋白受体在判断肝癌复发转移中的临床意义[J]．当代医学，2014,20(11):92-93．
|
|
[17]GIANNELLI G,KOUDELKOVA P,DITURI F,et al.Role of epithelial to mesenchymal transition in hepatocellular carcinoma[J].J Hepatol,2016,65(4):798-808．
|
|
[18]THIERY JP,ACLOQUE H,HUANG RY,et al.Epithelial-mesenchymal transitions in development and disease[J].Cell,2009,139(5):871-890．
|
|
[19]MANI SA,GUO W,LIAO MJ,et al.The epithelial-mesenchymal transition generates cells with properties of stem cells[J].Cell,2008,133(4):704-715．
|
|
[20]ANSIEAU S,BASTID J,DOREAU A,et al.Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence[J].Cancer Cell,2008,14(1):79-89．
|
|
[21]KUDO-SAITO C,SHIRAKO H,TAKEUCHI T,et al.Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells[J].Cancer Cell,2009,15(3):195-206．
|
|
[22]XU J,LAMOUILLE S,DERYNCK R.TGF-beta-induced epithelial to mesenchymal transition[J].Cell Res,2009,19(2):156-172．
|
|
[23]YANG Z,TAO Y,XU X,et al.Bufalin inhibits cell proliferation and migration of hepatocellular carcinoma cells via APOBEC3F induced intestinal immune network for Ig A production signaling pathway[J].Biochem Biophys Res Commun,2018,503(3):2124-2131．
|
|
[24]TORII S,YAMAMOTO T,TSUCHIYA Y,et al.ERK MAP kinase in G cell cycle progression and cancer[J].Cancer Sci,2006,97(8):697-702．
|
|
[25]CHANG F,STEELMAN LS,LEE JT,et al.Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors:Potential targeting for therapeutic intervention[J].Leukemia,2003,17(7):1263-1293．
|
|
[26]MCCUBREY JA,STEELMAN LS,CHAPPELL WH,et al.Roles of the Raf/MEK/ERK pathway in cell growth,malignant transformation and drug resistance[J].Biochim Biophys Acta,2007,1773(8):1263-1284．
|
|
[27] HANG JC,JIANG DQ,WANG ZS,et al.Role of plasma immunoglobulin receptor(PIgR/SC)in diagnosis of liver cancer[J].J Clin Psychos Dis,2016,22(z1):144-145.(in Chinese)黄继超，姜德清，王宗山，等．血浆多聚免疫球蛋白受体(PIgR/SC)对肝癌诊断的作用研究[J]．临床心身疾病杂志，2016,22(z1):144-145．
|
|
[28]TAN YH,SHANG YY,ZHANG T,et al.Current status and perspectives of multimodality therapy for hepatocellular carcinoma[J].J Clin Hepatol,2019,35(8):1858-1860.(in Chinese)谭运华，商阳阳，张涛，等．肝细胞癌综合治疗的现状和前景[J]．临床肝胆病杂志，2019,35(8):1858-1860．
|
|
[29]ZHENG WP,SHEN ZY.Risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma and related control strategies[J].J Clin Hepatol,2019,35(11):2391-2395.(in Chinese)郑卫萍，沈中阳．肝细胞癌肝移植术后肿瘤复发的危险因素与防治策略[J]．临床肝胆病杂志，2019,35(11):2391-2395．
|
|
[30]SAPISOCHIN G,BRUIX J.Liver transplantation for hepatocellular carcinoma:Outcomes and novel surgical approaches[J].Nat Rev Gastroenterol Hepatol,2017,14(4):203-217.
|
DownLoad: